Filing Details
- Accession Number:
- 0001645470-19-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-29 16:53:19
- Reporting Period:
- 2019-01-22
- Accepted Time:
- 2019-01-29 16:53:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-22 | 5,000 | $0.03 | 20,878,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-22 | 5,000 | $0.03 | 20,883,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-22 | 10,000 | $0.03 | 20,893,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-22 | 5,000 | $0.03 | 20,898,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-22 | 5,000 | $0.03 | 20,903,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-22 | 5,000 | $0.03 | 20,908,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-22 | 5,000 | $0.03 | 20,913,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-22 | 10,000 | $0.03 | 20,923,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-22 | 500 | $0.03 | 20,923,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-23 | 5,000 | $0.03 | 20,928,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-23 | 5,000 | $0.03 | 20,933,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-23 | 5,000 | $0.03 | 20,938,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-24 | 5,000 | $0.03 | 20,943,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-24 | 5,000 | $0.03 | 20,948,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-25 | 5,000 | $0.03 | 20,953,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-25 | 5,000 | $0.03 | 20,958,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-25 | 5,000 | $0.03 | 20,963,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-25 | 5,000 | $0.03 | 20,968,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-25 | 5,000 | $0.03 | 20,973,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-25 | 5,000 | $0.03 | 20,978,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-25 | 5,000 | $0.03 | 20,983,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-25 | 10,000 | $0.03 | 20,993,623 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
